The clock is ticking for Alex Rodriguez, as MLB is soon expected to announce a suspension for his alleged involvement with Biogenesis. But it could be unlike anything we were expecting.
According to the Associated Press, MLB could suspend Rodriguez under the collective bargaining agreement rather than the regular drug rules. This is potentially huge, as it would prevent him from playing if he appeals a suspension. Here’s what MLB could be thinking.
While use of banned performance-enhancing substances falls under the drug agreement, MLB may argue other alleged violations are punishable under the labor contract, a person familiar with management’s deliberations told the AP, speaking on condition of anonymity because no statements were authorized.
Taking that action would prevent the New York Yankees third baseman from returning to the field, even if he recovers from a quadriceps injury cited by the team as the reason for keeping him on the disabled list.
And merely threatening to use that provision might give MLB leverage to force a deal.
The report states that Rodriguez could be banned under Article XII B of the Basic Agreement, which states: “Players may be disciplined for just cause for conduct that is materially detrimental or materially prejudicial to the best interests of baseball including, but not limited to, engaging in conduct in violation of federal, state or local law.”
Yes, the “best interests of baseball” clause. If Rodriguez is suspended under that section, he would serve the penalty while a grievance is litigated. And as we heard from A-Rod’s lawyer earlier today, they have every intention to fight. The union would almost certainly fight it tooth and nail too, even if the evidence against Rodriguez is extensive. If they don’t, the drug agreement is basically rendered worthless. And you thought this was ugly before? We could be looking at a protracted and messy legal battle here.
The Rays have acquired shortstop Adeiny Hechavarria from the Marlins, Clark Spencer of the Miami Herald reports. The Marlins will receive minor league outfielder Braxton Lee and pitcher Ethan Clark. The Rays are expected to assume the remainder of Hechavarria’s $4.35 million salary for the 2017 season.
Hechavarria, 28, has only played in 20 games this season due to an oblique injury. He has mustered a meager .277/.288/.385 triple-slash line with four extra-base hits and six RBI across 67 plate appearances. He still plays decent defense, though, so that may be enough for him to take the everyday shortstop job in Tampa.
Lee, 23, was selected by the Rays in the 12th round of the 2014 draft. This season with Double-A Montgomery, his second stint there, Lee hit .318/.387/.391 over 296 PA.
Clark, 22, was taken in the 15th round of the 2015 draft by the Rays. In his first stint at Single-A in Bowling Green, Clark has a 3.11 ERA with a 50/18 K/BB ratio in 55 innings of work.
Tom Boswell of the Washington Post does frequent Q&As with readers and today he had quite the A to one of their Qs.
The question was about the Nats’ bullpen, which is obviously a glaring weakness on an otherwise excellent team. Following a long answer talking about the approach to bullpen construction, he dropped this:
On Friday, yet ANOTHER National simply walked up to me and said, “When the hell are they going to get this done? What are they waiting for? Waiting is just doing more damage.”
He didn’t even have to say what subject he was talking about or whom “they” were but it’s the bullpen and the Lerners.
A team has a problem when all a reporter has to do is say, “How’s it going?” and an established part of the team blasts the owners for not understanding what’s happening in their own dugout/clubhouse.
The Nats have a bit of a history venting to the Post’s reporters in ways a lot of players don’t vent, but that’s usually when things are going bad overall. These days, things are going pretty good for the Nats, the bum bullpen notwithstanding. I guess one weakness on an otherwise good team is annoying as hell.
But I guess now that they’re getting K-Rod, all of that will end.